Rhythm Biosciences Ltd has released a press release.
ColoSTAT Beta kit verification and validation update
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Breast Cancer Risk Study University of Melbourne
- Quarterly Activities Report and Appendix 4C 31 March 2025
- EGM - Investor Presentation
- RHY Genetype Commercial Sales
- RHY Investor Webinar
Later from Rhythm Biosciences
- NATA Accreditation Awarded for Genetype Laboratory
- FY2025 R&D Tax Incentive Loan Funding
- Jun 25 Quarterly Activities Report and Appendix 4C
- ColoSTAT Kits Deliver Breakthrough Results
- Response to ASX Price Query
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences